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4. For the logistic regression analyzing the relationship between
expanded ASHA coverage and increased vaccination coverage, we
dichotomized the change in ASHApresence at themedian, and split
vaccine coverage into two groups: increased and decreased vaccine
coverage.
Results: Across the 267 districts in 21 states studied, 40.83% of
villages within districts had ASHA workers in DLHS-3 on average,
compared to 77.83% in DLHS-4. From DLHS-3 to DLHS-4, the aver-
age district-level coverage changed from 93.04% to 88.73% for BCG,
77.81% to 78.46% forDPT, 78.35% to 80.21% for polio vaccine, 80.93%
to 79.08% for measles vaccine, and 62.88% to 50.95% for full vac-
cination. Greater than median increases in ASHA presence (≥30%)
withinadistrictwereassociatedwith1.733greateroddsof increase
in DPT coverage (95% CI: 1.036, 2.900) and 2.042 greater odds of
increase in measles vaccine coverage (95% CI: 1.215, 3.430).
Conclusion: Expanded ASHA coverage was not signiﬁcantly
associated with changes in BCG, polio vaccine, or full vaccina-
tion coverage. ASHAs are essential to connecting families in rural
areas with health care information and services. A critical aspect of
their position is the promotion of vaccines. Signiﬁcant associations
between increased presence of ASHA workers and increased DPT
and measles vaccination coverage at the district level in India cor-
roborate the importance of their work and may call for expansion
in their numbers and their role.
http://dx.doi.org/10.1016/j.ijid.2016.02.478
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Background: It is important and rather need of the hour to
unravel the risk of antimicrobial resistance from a public health
perspective in high burden countries such as India. The clinical
signiﬁcanceof isolatingmulti-drug resistant (MDR)E. coli fromhos-
pitalized patients merits sustained attention. The objective of this
study was to describe the evolution of antibiotic resistance and
to gather evidence on spread of antimicrobial resistance by clonal
expansion of clinical E. coli lineages.
Methods & Materials: A collection of 426 E. coli isolates was
analysed as three subsequent batches from two tertiary care hos-
pitals in India. The isolates were characterized by ERIC-based
ﬁngerprinting, O typing, phylogenetic grouping, MLST, virulence
proﬁling, phenotypic and genotypic antimicrobial resistance anal-
ysis and whole genome sequence (WGS) analysis. Our integrated
data were representative of a larger study aimed at understanding
transmission dynamics, population genetic structure and shap-
ing of antimicrobial resistance mechanisms in extraintestinal
pathogenic E. coli (ExPEC).
Results: We found that the resistance to unrelated antimicro-
bials is rapidly emerging in the form of ESBL-MDR phenotypes
(58%). The molecular epidemiology of antimicrobial resistance has
undergone a rapid change over the course of our study with
increase in ESBL, MDR and MBL rates from 31%, 50% and 0% to 86%,
95% and 28% respectively, as observed among the isolates studied
in 2009 and 2012. Also the faecal E. coli isolates (37%) exhibited the
acquisition of new ESBL variants such as CTX-M-15 instead of the
classical TEM and SHV types. Phylogenetic analysis revealed that
groups B2 and A were prevalent among clinical E. coli isolates (49%
and 27% respectively). REP-PCR, MLST and PFGE analyses suggest
that ExPEC strains are undergoing a sub-clonal evolution as demon-
strated by the identiﬁcation of ST131 E. coli in our collection (42%).
E. coli ST131 was initially identiﬁed to be linked to the spread of
ﬂuoroquinolone resistance and CTX-M-15 extended-spectrum -
lactamase (ESBL) production. Alarmingly, ST131 strains harbouring
NDM-1 (1.5%) carbapenem resistance were also identiﬁed.
Conclusion: This study suggests that clinical E. coli from India
are strongly associated with CTX-M-15 enzyme and are clonally
evolving with a potential for newer acquisitions and wide spread
dissemination of antimicrobial resistance genes.
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Background: TheRabiesvirus is transmitted tohumansviabites
or scratches from infectedanimals.Whendiseasedevelops it is con-
sidered incurable. The Rabies Virus Disease (RVD) is preventable
through vaccination or immunoglobulin administration immedi-
ately after exposure. Even though, RVD transmitted via solid organ
transplantationhasbeendocumented in literature, theactual expo-
sure risk to Healthcare workers (HCWs) remains undetermined.
This study reviews the intervention and outcome following an
infection control investigation of two solid organ recipients who
developed RVD from a single donor. Two months after relocating
from India to a neighboring gulf country, the donor died after pre-
sentingwith nonspeciﬁc symptoms that included encephalitis. The
donor’s organs were harvested, with the heart and liver sent to a
large teaching hospital located in Riyadh, Saudi Arabia. It was not
until the RVD investigation was undertaken that it was known that
the donor had been bitten by a dog approximately three months
prior to death.
Methods & Materials: A retrospective chart review and inter-
views were undertaken to identify those exposed to recipients
suspected RVD. RVD was conﬁrmed by brain biopsy. Review of
the Safety Reporting System (SRS) was undertaken to identify any
HCWs exposed to the recipient’s blood or body ﬂuids.
A screening tool for HCWswas developed to identify the level of
exposure risk, and if post-exposureprophylaxis (PEP)was required.
A Rabies Clinic was implemented during the investigation period
to facilitate the interview and screening process. Collaboration
